Héma-Québec Awards Takeda Canada Two-Year Tender for Hereditary Angioedema treatment TAKHZYRO®
TORONTO, Ontario, April 28, 2022 – Takeda Canada Inc. is pleased to announce that Héma-Québec has awarded a two-year tender for TAKHZYRO® (lanadelumab injection) as the sole option for...